United States Healthcare Equipment & Supplies

Boston Scientific Corp (BSX)

Boston Scientific Corp experienced a single insider purchase totaling approximately $100,408 over the past ninety days. This activity follows recent market volatility, with the stock price declining 15.3% during this period. No executive-level selling occurred recently, despite the company's last earnings report showing no deviation from expected performance metrics.
Ticker: BSX Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Boston Scientific Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Morano Susan E Non-Executive Director
Transaction date
Purchase
Price
342.87
Quantity 99,998 +13.8%
Value US$4,130,148
2.3
Habiger David C Non-Executive Director
Transaction date
Purchase
Price
478.72
Quantity 84,344 -34.8%
Value US$4,305,295
2.3
Habiger David C Non-Executive Director
Transaction date
Purchase
Price
251.28
Quantity 71,272 -20.2%
Value US$2,021,812
2.8
Mahoney Michael F Chairman, President & CEO Executive Director
Transaction date
Purchase
Price
48.33
Quantity 186,240 +13.3%
Value US$9,001,408
2.3
Habiger David C Non-Executive Director
Transaction date
Purchase
Price
48.07
Quantity 1,042 +7.5%
Value US$50,084
3.1
LUDWIG EDWARD J Non-Executive Director
Transaction date
Purchase
Price
45.48
Quantity 5,000 +19.7%
Value US$227,400
2.0
Pegus Cheryl Non-Executive Director
Transaction date
Purchase
Price
56.49
Quantity 1,770 New position
Value US$99,987
2.3
Habiger David C Non-Executive Director
Transaction date
Purchase
Price
55.92
Quantity 2,250 +19.3%
Value US$125,819
3.1
LUDWIG EDWARD J Non-Executive Director
Transaction date
Purchase
Price
56.68
Quantity 3,580 +16.4%
Value US$202,914
2.3
Habiger David C Non-Executive Director
Transaction date
Purchase
Price
56.95
Quantity 2,200 +23.3%
Value US$125,279
2.8
Mahoney Michael F Chairman, President & CEO Executive Director
Transaction date
Planned sale
Price
93.49
Quantity 159,701 -10.2%
Value US$14,930,526
2.8
Mahoney Michael F Chairman, President & CEO Executive Director
Transaction date
Planned sale
Price
94.06
Quantity 1,200 -0.1%
Value US$112,868
2.8
Mahoney Michael F Chairman, President & CEO Executive Director
Transaction date
Planned sale
Price
93.49
Quantity 159,701 -10.2%
Value US$14,930,526
2.8
Mahoney Michael F Chairman, President & CEO Executive Director
Transaction date
Planned sale
Price
94.06
Quantity 1,200 -0.1%
Value US$112,868
2.8
MICHAEL F MAHONEY Officer; Director Executive Director
Transaction date
Proposed sale
Price
93.49
Quantity 160,901
Value US$15,043,390
2.2
Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Officer
Transaction date
Planned sale
Price
101.55
Quantity 17,313 -42.3%
Value US$1,758,189
2.2
ARTHUR C BUTCHER Officer Officer
Transaction date
Proposed sale
Price
101.55
Quantity 17,313
Value US$1,758,188
Zane Ellen M Director Non-Executive Director
Transaction date
Proposed sale
Price
97.96
Quantity 2,901
Value US$284,171
Zane Ellen M Non-Executive Director
Transaction date
Planned sale
Price
98.28
Quantity 12,891 -34.8%
Value US$1,266,978
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Officer
Transaction date
Planned sale
Price
99.14
Quantity 29,472 -14.2%
Value US$2,921,895
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Officer
Transaction date
Planned sale
Price
99.76
Quantity 16,928 -7.5%
Value US$1,688,749
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Officer
Transaction date
Planned sale
Price
100.75
Quantity 3,600 -1.6%
Value US$362,693
JOSEPH M FITZGERALD Officer Officer
Transaction date
Proposed sale
Price
99.47
Quantity 50,000
Value US$4,973,335
Zane Ellen M Director Non-Executive Director
Transaction date
Proposed sale
Price
102.24
Quantity 2,901
Value US$296,592
Zane Ellen M Non-Executive Director
Transaction date
Planned sale
Price
102.24
Quantity 2,901 -10.7%
Value US$296,599
Zane Ellen M Non-Executive Director
Transaction date
Planned sale
Price
101.13
Quantity 9,990 -27.0%
Value US$1,010,301
Zane Ellen M Director Non-Executive Director
Transaction date
Proposed sale
Price
100.91
Quantity 9,990
Value US$1,008,081
JOSEPH M FITZGERALD Officer Officer
Transaction date
Proposed sale
Price
98.47
Quantity 50,000
Value US$4,923,325
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Officer
Transaction date
Planned sale
Price
98.38
Quantity 41,755 -19.0%
Value US$4,107,844
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Officer
Transaction date
Planned sale
Price
98.91
Quantity 8,245 -3.6%
Value US$815,482
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Officer
Transaction date
Planned sale
Price
105.85
Quantity 28,170 -13.6%
Value US$2,981,755
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Officer
Transaction date
Planned sale
Price
104.89
Quantity 21,830 -9.6%
Value US$2,289,661
JOSEPH M FITZGERALD Officer Officer
Transaction date
Proposed sale
Price
105.43
Quantity 50,000
Value US$5,271,415
2.2
Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Officer
Transaction date
Planned sale
Price
104.63
Quantity 17,313 -42.3%
Value US$1,811,520
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Officer
Transaction date
Planned sale
Price
104.63
Quantity 50,000 -21.9%
Value US$5,231,670
2.2
ARTHUR C BUTCHER Officer Officer
Transaction date
Proposed sale
Price
104.63
Quantity 17,313
Value US$1,811,519
JOSEPH M FITZGERALD Officer Officer
Transaction date
Proposed sale
Price
104.63
Quantity 50,000
Value US$5,231,665
2.7
FUJIMORI YOSHIAKI Non-Executive Director
Transaction date
Sale
Price
106.99
Quantity 2,901 -58.2%
Value US$310,378
2.7
YOSHIAKI FUJIMORI Director Non-Executive Director
Transaction date
Proposed sale
Price
106.99
Quantity 2,901
Value US$310,378
3.1
LUDWIG EDWARD J Non-Executive Director
Transaction date
Sale
Price
106.03
Quantity 4,000 -17.8%
Value US$424,120
3.1
LUDWIG EDWARD J Director Non-Executive Director
Transaction date
Proposed sale
Price
107.46
Quantity 4,000
Value US$429,840
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Officer
Transaction date
Planned sale
Price
106.97
Quantity 50,000 -21.9%
Value US$5,348,315
JOSEPH M FITZGERALD Officer Officer
Transaction date
Proposed sale
Price
106.97
Quantity 50,000
Value US$5,348,310
JOSEPH M FITZGERALD Officer Officer
Transaction date
Proposed sale
Price
102.88
Quantity 56,372
Value US$5,799,625
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Officer
Transaction date
Planned sale
Price
102.88
Quantity 56,372 -24.0%
Value US$5,799,630
2.8
Mahoney Michael F Chairman, President & CEO Executive Director
Transaction date
Planned sale
Price
103.39
Quantity 89,921 -5.7%
Value US$9,296,950
2.8
Mahoney Michael F Chairman, President & CEO Executive Director
Transaction date
Planned sale
Price
104.05
Quantity 74,522 -4.5%
Value US$7,754,186
2.8
MICHAEL F MAHONEY Officer; Director Executive Director
Transaction date
Proposed sale
Price
103.69
Quantity 164,443
Value US$17,051,132
3.1
LUDWIG EDWARD J Non-Executive Director
Transaction date
Sale
Price
104.59
Quantity 4,000 -15.1%
Value US$418,368
3.1
LUDWIG EDWARD J Director Non-Executive Director
Transaction date
Proposed sale
Price
104.54
Quantity 4,000
Value US$418,160
Brown Vance R SVP, GC and Corp. Secretary Officer
Transaction date
Planned sale
Price
106.42
Quantity 4,826 -13.3%
Value US$513,583
VANCE BROWN Officer Officer
Transaction date
Proposed sale
Price
106.42
Quantity 4,826
Value US$513,583
3.7
Sorenson John Bradley EVP, Global Operations Officer
Transaction date
Planned sale
Price
104.54
Quantity 4,572 -19.6%
Value US$477,957
3.7
JOHN B SORENSON Officer Officer
Transaction date
Proposed sale
Price
104.54
Quantity 4,572
Value US$477,957
2.2
Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Officer
Transaction date
Planned sale
Price
102.06
Quantity 17,314 -43.8%
Value US$1,766,982
2.8
Mahoney Michael F Chairman, President & CEO Executive Director
Transaction date
Planned sale
Price
102.13
Quantity 91,282 -5.6%
Value US$9,322,266
2.8
Mahoney Michael F Chairman, President & CEO Executive Director
Transaction date
Planned sale
Price
102.92
Quantity 73,161 -4.3%
Value US$7,529,708
2.8
MICHAEL F MAHONEY Officer; Director Executive Director
Transaction date
Proposed sale
Price
102.48
Quantity 164,443
Value US$16,851,966
2.2
ARTHUR C BUTCHER Officer Officer
Transaction date
Proposed sale
Price
102.06
Quantity 17,314
Value US$1,766,981
Brown Vance R SVP, GC and Corp. Secretary Officer
Transaction date
Planned sale
Price
95.09
Quantity 4,826 -11.8%
Value US$458,904
VANCE BROWN Officer Officer
Transaction date
Proposed sale
Price
95.09
Quantity 4,826
Value US$458,904
2.8
Mahoney Michael F Chairman, President & CEO Executive Director
Transaction date
Planned sale
Price
100.01
Quantity 164,442 -9.3%
Value US$16,445,072
2.8
MICHAEL F MAHONEY Officer; Director Executive Director
Transaction date
Proposed sale
Price
100.01
Quantity 164,442
Value US$16,445,068
Brown Vance R SVP, GC and Corp. Secretary Officer
Transaction date
Planned sale
Price
100.85
Quantity 4,826 -10.5%
Value US$486,702
VANCE BROWN Officer Officer
Transaction date
Proposed sale
Price
100.85
Quantity 4,826
Value US$486,702
Woodworth Emily SVP, Global Controller and CAO Officer
Transaction date
Planned sale
Price
104.63
Quantity 482 -52.7%
Value US$50,432
Woodworth Emily SVP, Global Controller and CAO Officer
Transaction date
Planned sale
Price
104.97
Quantity 7,149 -88.7%
Value US$750,465
Woodworth Emily SVP, Global Controller and CAO Officer
Transaction date
Planned sale
Price
101.13
Quantity 9,887 -85.8%
Value US$999,872
JEFFREY B MIRVISS Officer Officer
Transaction date
Proposed sale
Price
104.00
Quantity 2,688
Value US$279,552
Mirviss Jeffrey B. EVP&Pres, Periph Intervent Officer
Transaction date
Planned sale
Price
104.00
Quantity 2,688 -9.4%
Value US$279,552
Mirviss Jeffrey B. EVP&Pres, Periph Intervent Officer
Transaction date
Planned sale
Price
104.25
Quantity 4,675 -14.1%
Value US$487,369
Zane Ellen M Director Non-Executive Director
Transaction date
Proposed sale
Price
104.23
Quantity 13,586
Value US$1,416,088
JEFFREY B MIRVISS Officer Officer
Transaction date
Proposed sale
Price
104.25
Quantity 4,675
Value US$487,369
Zane Ellen M Non-Executive Director
Transaction date
Planned sale
Price
104.23
Quantity 13,586 -28.0%
Value US$1,416,134
VANCE BROWN Officer Officer
Transaction date
Proposed sale
Price
104.64
Quantity 4,826
Value US$504,993
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-26 2026-08-25 B Purchase
Morano Susan E
Non-Executive Director
99,998 +13.8%
342.87
US$4,130,148 		99,998 +13.8% 342.87 US$4,130,148
2026-08-07 2026-08-05 B Purchase
2.3
Habiger David C
Non-Executive Director
84,344 -34.8%
478.72
US$4,305,295 		84,344 -34.8% 478.72 US$4,305,295
2026-08-05 2026-08-04 B Purchase
2.3
Habiger David C
Non-Executive Director
71,272 -20.2%
251.28
US$2,021,812 		71,272 -20.2% 251.28 US$2,021,812
2026-08-05 2026-08-03 B Purchase
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
186,240 +13.3%
48.33
US$9,001,408 		186,240 +13.3% 48.33 US$9,001,408
2026-08-05 2026-08-03 B Purchase
2.3
Habiger David C
Non-Executive Director
1,042 +7.5%
48.07
US$50,084 		1,042 +7.5% 48.07 US$50,084
2026-08-03 2026-07-31 B Purchase
3.1
LUDWIG EDWARD J
Non-Executive Director
5,000 +19.7%
45.48
US$227,400 		5,000 +19.7% 45.48 US$227,400
2026-05-21 2026-05-20 B Purchase
2.0
Pegus Cheryl
Non-Executive Director
1,770 New position
56.49
US$99,987 		1,770 New position 56.49 US$99,987
2026-05-21 2026-05-20 B Purchase
2.3
Habiger David C
Non-Executive Director
2,250 +19.3%
55.92
US$125,819 		2,250 +19.3% 55.92 US$125,819
2026-05-21 2026-05-20 B Purchase
3.1
LUDWIG EDWARD J
Non-Executive Director
3,580 +16.4%
56.68
US$202,914 		3,580 +16.4% 56.68 US$202,914
2026-05-21 2026-05-19 B Purchase
2.3
Habiger David C
Non-Executive Director
2,200 +23.3%
56.95
US$125,279 		2,200 +23.3% 56.95 US$125,279
2026-02-03 2026-02-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
159,701 -10.2%
93.49
US$14,930,526 		159,701 -10.2% 93.49 US$14,930,526
2026-02-03 2026-02-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
1,200 -0.1%
94.06
US$112,868 		1,200 -0.1% 94.06 US$112,868
2026-02-03 2026-02-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
159,701 -10.2%
93.49
US$14,930,526 		159,701 -10.2% 93.49 US$14,930,526
2026-02-03 2026-02-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
1,200 -0.1%
94.06
US$112,868 		1,200 -0.1% 94.06 US$112,868
2026-02-02 2026-02-02 PrS Proposed sale
2.8
MICHAEL F MAHONEY

Officer; Director

Executive Director
160,901
93.49
US$15,043,390 		160,901 93.49 US$15,043,390
2025-12-02 2025-12-01 PlS Planned sale
2.2
Butcher Arthur C

EVP& Grp Pres, MedSurg & APAC

Officer
17,313 -42.3%
101.55
US$1,758,189 		17,313 -42.3% 101.55 US$1,758,189
2025-12-01 2025-12-01 PrS Proposed sale
2.2
ARTHUR C BUTCHER

Officer

Officer
17,313
101.55
US$1,758,188 		17,313 101.55 US$1,758,188
2025-11-06 2025-11-06 PrS Proposed sale
Zane Ellen M

Director

Non-Executive Director
2,901
97.96
US$284,171 		2,901 97.96 US$284,171
2025-11-06 2025-11-06 PlS Planned sale
Zane Ellen M
Non-Executive Director
12,891 -34.8%
98.28
US$1,266,978 		12,891 -34.8% 98.28 US$1,266,978
2025-11-04 2025-11-03 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
29,472 -14.2%
99.14
US$2,921,895 		29,472 -14.2% 99.14 US$2,921,895
2025-11-04 2025-11-03 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
16,928 -7.5%
99.76
US$1,688,749 		16,928 -7.5% 99.76 US$1,688,749
2025-11-04 2025-11-03 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
3,600 -1.6%
100.75
US$362,693 		3,600 -1.6% 100.75 US$362,693
2025-11-03 2025-11-03 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
50,000
99.47
US$4,973,335 		50,000 99.47 US$4,973,335
2025-10-28 2025-10-28 PrS Proposed sale
Zane Ellen M

Director

Non-Executive Director
2,901
102.24
US$296,592 		2,901 102.24 US$296,592
2025-10-28 2025-10-28 PlS Planned sale
Zane Ellen M
Non-Executive Director
2,901 -10.7%
102.24
US$296,599 		2,901 -10.7% 102.24 US$296,599
2025-10-28 2025-10-27 PlS Planned sale
Zane Ellen M
Non-Executive Director
9,990 -27.0%
101.13
US$1,010,301 		9,990 -27.0% 101.13 US$1,010,301
2025-10-27 2025-10-27 PrS Proposed sale
Zane Ellen M

Director

Non-Executive Director
9,990
100.91
US$1,008,081 		9,990 100.91 US$1,008,081
2025-10-01 2025-10-01 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
50,000
98.47
US$4,923,325 		50,000 98.47 US$4,923,325
2025-10-01 2025-10-01 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
41,755 -19.0%
98.38
US$4,107,844 		41,755 -19.0% 98.38 US$4,107,844
2025-10-01 2025-10-01 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
8,245 -3.6%
98.91
US$815,482 		8,245 -3.6% 98.91 US$815,482
2025-09-03 2025-09-02 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
28,170 -13.6%
105.85
US$2,981,755 		28,170 -13.6% 105.85 US$2,981,755
2025-09-03 2025-09-02 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
21,830 -9.6%
104.89
US$2,289,661 		21,830 -9.6% 104.89 US$2,289,661
2025-09-02 2025-09-02 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
50,000
105.43
US$5,271,415 		50,000 105.43 US$5,271,415
2025-08-04 2025-08-01 PlS Planned sale
2.2
Butcher Arthur C

EVP& Grp Pres, MedSurg & APAC

Officer
17,313 -42.3%
104.63
US$1,811,520 		17,313 -42.3% 104.63 US$1,811,520
2025-08-04 2025-08-01 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
50,000 -21.9%
104.63
US$5,231,670 		50,000 -21.9% 104.63 US$5,231,670
2025-08-01 2025-08-01 PrS Proposed sale
2.2
ARTHUR C BUTCHER

Officer

Officer
17,313
104.63
US$1,811,519 		17,313 104.63 US$1,811,519
2025-08-01 2025-08-01 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
50,000
104.63
US$5,231,665 		50,000 104.63 US$5,231,665
2025-07-30 2025-07-29 S Sale
2.7
FUJIMORI YOSHIAKI
Non-Executive Director
2,901 -58.2%
106.99
US$310,378 		2,901 -58.2% 106.99 US$310,378
2025-07-29 2025-07-29 PrS Proposed sale
2.7
YOSHIAKI FUJIMORI

Director

Non-Executive Director
2,901
106.99
US$310,378 		2,901 106.99 US$310,378
2025-07-28 2025-07-25 S Sale
3.1
LUDWIG EDWARD J
Non-Executive Director
4,000 -17.8%
106.03
US$424,120 		4,000 -17.8% 106.03 US$424,120
2025-07-25 2025-07-25 PrS Proposed sale
3.1
LUDWIG EDWARD J

Director

Non-Executive Director
4,000
107.46
US$429,840 		4,000 107.46 US$429,840
2025-07-02 2025-07-01 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
50,000 -21.9%
106.97
US$5,348,315 		50,000 -21.9% 106.97 US$5,348,315
2025-07-01 2025-07-01 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
50,000
106.97
US$5,348,310 		50,000 106.97 US$5,348,310
2025-06-04 2025-06-04 PrS Proposed sale
JOSEPH M FITZGERALD

Officer

Officer
56,372
102.88
US$5,799,625 		56,372 102.88 US$5,799,625
2025-06-04 2025-06-04 PlS Planned sale
Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Officer
56,372 -24.0%
102.88
US$5,799,630 		56,372 -24.0% 102.88 US$5,799,630
2025-06-03 2025-06-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
89,921 -5.7%
103.39
US$9,296,950 		89,921 -5.7% 103.39 US$9,296,950
2025-06-03 2025-06-02 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
74,522 -4.5%
104.05
US$7,754,186 		74,522 -4.5% 104.05 US$7,754,186
2025-06-02 2025-06-02 PrS Proposed sale
2.8
MICHAEL F MAHONEY

Officer; Director

Executive Director
164,443
103.69
US$17,051,132 		164,443 103.69 US$17,051,132
2025-05-30 2025-05-29 S Sale
3.1
LUDWIG EDWARD J
Non-Executive Director
4,000 -15.1%
104.59
US$418,368 		4,000 -15.1% 104.59 US$418,368
2025-05-29 2025-05-29 PrS Proposed sale
3.1
LUDWIG EDWARD J

Director

Non-Executive Director
4,000
104.54
US$418,160 		4,000 104.54 US$418,160
2025-05-22 2025-05-21 PlS Planned sale
Brown Vance R

SVP, GC and Corp. Secretary

Officer
4,826 -13.3%
106.42
US$513,583 		4,826 -13.3% 106.42 US$513,583
2025-05-21 2025-05-21 PrS Proposed sale
VANCE BROWN

Officer

Officer
4,826
106.42
US$513,583 		4,826 106.42 US$513,583
2025-05-06 2025-05-05 PlS Planned sale
3.7
Sorenson John Bradley

EVP, Global Operations

Officer
4,572 -19.6%
104.54
US$477,957 		4,572 -19.6% 104.54 US$477,957
2025-05-05 2025-05-05 PrS Proposed sale
3.7
JOHN B SORENSON

Officer

Officer
4,572
104.54
US$477,957 		4,572 104.54 US$477,957
2025-05-05 2025-05-01 PlS Planned sale
2.2
Butcher Arthur C

EVP& Grp Pres, MedSurg & APAC

Officer
17,314 -43.8%
102.06
US$1,766,982 		17,314 -43.8% 102.06 US$1,766,982
2025-05-05 2025-05-01 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
91,282 -5.6%
102.13
US$9,322,266 		91,282 -5.6% 102.13 US$9,322,266
2025-05-05 2025-05-01 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
73,161 -4.3%
102.92
US$7,529,708 		73,161 -4.3% 102.92 US$7,529,708
2025-05-01 2025-05-01 PrS Proposed sale
2.8
MICHAEL F MAHONEY

Officer; Director

Executive Director
164,443
102.48
US$16,851,966 		164,443 102.48 US$16,851,966
2025-05-01 2025-05-01 PrS Proposed sale
2.2
ARTHUR C BUTCHER

Officer

Officer
17,314
102.06
US$1,766,981 		17,314 102.06 US$1,766,981
2025-04-22 2025-04-21 PlS Planned sale
Brown Vance R

SVP, GC and Corp. Secretary

Officer
4,826 -11.8%
95.09
US$458,904 		4,826 -11.8% 95.09 US$458,904
2025-04-21 2025-04-21 PrS Proposed sale
VANCE BROWN

Officer

Officer
4,826
95.09
US$458,904 		4,826 95.09 US$458,904
2025-04-02 2025-04-01 PlS Planned sale
2.8
Mahoney Michael F

Chairman, President & CEO

Executive Director
164,442 -9.3%
100.01
US$16,445,072 		164,442 -9.3% 100.01 US$16,445,072
2025-04-01 2025-04-01 PrS Proposed sale
2.8
MICHAEL F MAHONEY

Officer; Director

Executive Director
164,442
100.01
US$16,445,068 		164,442 100.01 US$16,445,068
2025-03-24 2025-03-21 PlS Planned sale
Brown Vance R

SVP, GC and Corp. Secretary

Officer
4,826 -10.5%
100.85
US$486,702 		4,826 -10.5% 100.85 US$486,702
2025-03-21 2025-03-21 PrS Proposed sale
VANCE BROWN

Officer

Officer
4,826
100.85
US$486,702 		4,826 100.85 US$486,702
2025-03-05 2025-03-04 PlS Planned sale
Woodworth Emily

SVP, Global Controller and CAO

Officer
482 -52.7%
104.63
US$50,432 		482 -52.7% 104.63 US$50,432
2025-03-05 2025-03-03 PlS Planned sale
Woodworth Emily

SVP, Global Controller and CAO

Officer
7,149 -88.7%
104.97
US$750,465 		7,149 -88.7% 104.97 US$750,465
2025-03-03 2025-02-28 PlS Planned sale
Woodworth Emily

SVP, Global Controller and CAO

Officer
9,887 -85.8%
101.13
US$999,872 		9,887 -85.8% 101.13 US$999,872
2025-02-25 2025-02-25 PrS Proposed sale
JEFFREY B MIRVISS

Officer

Officer
2,688
104.00
US$279,552 		2,688 104.00 US$279,552
2025-02-25 2025-02-25 PlS Planned sale
Mirviss Jeffrey B.

EVP&Pres, Periph Intervent

Officer
2,688 -9.4%
104.00
US$279,552 		2,688 -9.4% 104.00 US$279,552
2025-02-25 2025-02-24 PlS Planned sale
Mirviss Jeffrey B.

EVP&Pres, Periph Intervent

Officer
4,675 -14.1%
104.25
US$487,369 		4,675 -14.1% 104.25 US$487,369
2025-02-24 2025-02-24 PrS Proposed sale
Zane Ellen M

Director

Non-Executive Director
13,586
104.23
US$1,416,088 		13,586 104.23 US$1,416,088
2025-02-24 2025-02-24 PrS Proposed sale
JEFFREY B MIRVISS

Officer

Officer
4,675
104.25
US$487,369 		4,675 104.25 US$487,369
2025-02-24 2025-02-24 PlS Planned sale
Zane Ellen M
Non-Executive Director
13,586 -28.0%
104.23
US$1,416,134 		13,586 -28.0% 104.23 US$1,416,134
2025-02-21 2025-02-21 PrS Proposed sale
VANCE BROWN

Officer

Officer
4,826
104.64
US$504,993 		4,826 104.64 US$504,993

See older Boston Scientific Corp insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Boston Scientific Corp history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Boston Scientific Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America
Insider trades in S&P 500